![Ending Prescription Drug ‘Product Hopping’ Could Save $4.7 Billion Annually](https://getmga.com/wp-content/uploads/2022/04/iStock-174963499.jpg)
Ending Prescription Drug ‘Product Hopping’ Could Save $4.7 Billion Annually
“The report finds that extending patents on just those five drugs [Prilosec, TriCor, Suboxone, Doryx, and Namenda] will result in a cost to the U.S. health care system of $4.7 billion annually—money that in theory could have been saved if the drugs had been available in a generic form.”